Longitudinal Analysis of the T-cell Receptor Repertoire in Graft-infiltrating Lymphocytes Following Hand Transplantation.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
pubmed:
20
11
2020
medline:
27
7
2021
entrez:
19
11
2020
Statut:
ppublish
Résumé
T lymphocyte-mediated acute rejection is a significant complication following solid organ transplantation. Standard methods of monitoring for acute rejection rely on assessing histological tissue damage but do not define the immunopathogenesis. Additionally, current therapies for rejection broadly blunt cellular immunity, creating a high risk for opportunistic infections. There is, therefore, a need to better understand the process of acute cellular rejection to help develop improved prognostic tests and narrowly targeted therapies. Through next-generation sequencing, we characterized and compared the clonal T-cell receptor (TCR) repertoires of graft-infiltrating lymphocytes (GILs) and blood-derived lymphocytes from a hand transplant recipient over 420 days following transplantation. We also tracked the TCR clonal persistence and V beta (BV) gene usage, evaluating overlap between these 2 compartments. TCR repertoires of blood and GIL populations remained distinct throughout the sampling period, and differential BV usage was consistently seen between these compartments. GIL TCR clones persisted over time and were seen in only limited frequency in the blood T-lymphocyte populations. We demonstrate that blood monitoring of TCR clones does not reveal the pathogenic process of acute cellular rejection in transplanted tissue. GILs show clonal persistence with biased BV usage, suggesting that tissue TCR clonal monitoring could be useful, although a deeper understanding is necessary to prognosticate rejection based on TCR clonal repertoires. Finally, the distinct TCR BV usage bias in GILs raises the possibility for prevention and therapy of acute cellular rejection based on targeting of specific TCR clones.
Sections du résumé
BACKGROUND
T lymphocyte-mediated acute rejection is a significant complication following solid organ transplantation. Standard methods of monitoring for acute rejection rely on assessing histological tissue damage but do not define the immunopathogenesis. Additionally, current therapies for rejection broadly blunt cellular immunity, creating a high risk for opportunistic infections. There is, therefore, a need to better understand the process of acute cellular rejection to help develop improved prognostic tests and narrowly targeted therapies.
METHODS
Through next-generation sequencing, we characterized and compared the clonal T-cell receptor (TCR) repertoires of graft-infiltrating lymphocytes (GILs) and blood-derived lymphocytes from a hand transplant recipient over 420 days following transplantation. We also tracked the TCR clonal persistence and V beta (BV) gene usage, evaluating overlap between these 2 compartments.
RESULTS
TCR repertoires of blood and GIL populations remained distinct throughout the sampling period, and differential BV usage was consistently seen between these compartments. GIL TCR clones persisted over time and were seen in only limited frequency in the blood T-lymphocyte populations.
CONCLUSIONS
We demonstrate that blood monitoring of TCR clones does not reveal the pathogenic process of acute cellular rejection in transplanted tissue. GILs show clonal persistence with biased BV usage, suggesting that tissue TCR clonal monitoring could be useful, although a deeper understanding is necessary to prognosticate rejection based on TCR clonal repertoires. Finally, the distinct TCR BV usage bias in GILs raises the possibility for prevention and therapy of acute cellular rejection based on targeting of specific TCR clones.
Identifiants
pubmed: 33208695
pii: 00007890-202107000-00016
doi: 10.1097/TP.0000000000003535
pmc: PMC8221714
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1502-1509Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002003
Pays : United States
Informations de copyright
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015; 150:252–259
Kaufman CL, Bhutiani N, Ramirez A, et al. Current status of vascularized composite allotransplantation. Am Surg. 2019; 85:631–637
Shores JT, Malek V, Lee WPA, et al. Outcomes after hand and upper extremity transplantation. J Mater Sci Mater Med. 2017; 28:72
Bonastre J, Landin L, Diez J, et al. Factors influencing acute rejection of human hand allografts: a systematic review. Ann Plast Surg. 2012; 68:624–629
Hein RE, Ruch DS, Klifto CS, et al. Hand transplantation in the United States: a review of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Database. Am J Transplant. 2020; 20:1417–1423
Berglund E, Andersen Ljungdahl M, Bogdanović D, et al. Clinical significance of alloantibodies in hand transplantation: a multicenter study. Transplantation. 2019; 103:2173–2182
Sanromán Budiño B, Vázquez Martul E, Pértega Díaz S, et al. Autopsy-determined causes of death in solid organ transplant recipients. Transplant Proc. 2004; 36:787–789
Landin L, Bonastre J, Casado-Sanchez C, et al. Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review. Transplant Int. 2012; 25:424–432
Ali JM, Bolton EM, Bradley JA, et al. Allorecognition pathways in transplant rejection and tolerance. Transplantation. 2013; 96:681–688
Bonneville M, Moreau JF, Blokland E, et al. T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones. J Immunol. 1988; 141:4187–4195
Finn OJ, Miceli MC, Sanfilippo A, et al. In vitro and in vivo human T cell repertoire in kidney allograft rejection. Transplant Proc. 1988; 20:155–158
McWhinnie DL, Thompson JF, Taylor HM, et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation. 1986; 42:352–358
Datema G, Vaessen LM, Daane CR, et al. T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantation. Transplant Proc. 1993; 25Pt 177–79
DeBruyne LA, Lynch JP III, Baker LA, et al. Restricted V beta usage by T cells infiltrating rejecting human lung allografts. J Immunol. 1996; 156:3493–3500
Paraoan MT, Bakran A, Hammad A, et al. Mixed lymphocyte cultures can predict TCR Vbeta repertoires of T cells infiltrating kidney transplants during acute rejection episodes. Transplantation. 2005; 80:1805–1808
Kim JY, Balamurugan A, Azari K, et al. Clonal CD8+ T cell persistence and variable gene usage bias in a human transplanted hand. PLoS One. 2015; 10:e0136235
Morris H, DeWolf S, Robins H, et al. Tracking donor-reactive T cells: evidence for clonal deletion in tolerant kidney transplant patients. Sci Transl Med. 2015; 7:272ra10
Zuber J, Shonts B, Lau SP, et al. Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome. Sci Immunology. 2016; 1::eaah3732
Dziubianau M, Hecht J, Kuchenbecker L, et al. TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology. Am J Transplant. 2013; 13:2842–2854
DeWolf S, Grinshpun B, Savage T, et al. Quantifying size and diversity of the human T cell alloresponse. JCI Insight. 2018; 3::e121256
DeWolf S, Shen Y, Sykes M. A new window into the human alloresponse. Transplantation. 2016; 100:1639–1649
Zeng G, Huang Y, Huang Y, et al. Antigen-specificity of T cell infiltrates in biopsies with T cell-mediated rejection and BK polyomavirus viremia: analysis by next generation sequencing. Am J Transplant. 2016; 16:3131–3138
Barth C, Von Menges A, Zanker B, et al. Restricted T cell V beta repertoire in renal allografts during acute and chronic rejection. Kidney Int. 1996; 50:2020–2026
Mannon RB, Kotzin BL, Roper E, et al. The intragraft CD8+ T cell response in renal allograft rejection in the mouse. Transplantation. 1996; 62:96–104
Obata F, Yoshida K, Ikeda Y, et al. Clonality analysis of T cells mediating acute and chronic rejection in kidney allografts. Transpl Immunol. 2004; 13:233–237
Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993; 44:411–422
Wong JT, Colvin RB. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J Immunol. 1987; 139:1369–1374
Bolotin DA, Poslavsky S, Mitrophanov I, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015; 12:380–381
McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012; 40:4288–4297
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc. 1995; 57:289–300
Alachkar H, Mutonga M, Kato T, et al. Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection. BMC Nephrol. 2016; 17:181
Alvarez CM, Opelz G, Giraldo MC, et al. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant. 2005; 5Pt 1746–756
Carlquist JF, Hammond ME, Yowell RL, et al. Correlation between cellular rejection of cardiac allografts and quantitative changes among T-cell subsets identified by V beta epitope expression. Circulation. 1994; 90:686–693
Finn OJ, Miceli MC. Effector T-cell repertoire selection in human allograft rejection. Transplant Proc. 1989; 21Pt 1346–348
Hall BL, Finn OJ. T cell receptor V beta gene usage in allograft-derived cell lines analyzed by a polymerase chain reaction technique. Transplantation. 1992; 53:1088–1099
Goss JA, Pyo R, Flye MW, et al. Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of V beta+ T cells. J Exp Med. 1993; 177:35–44
Ibarrondo FJ, Anton PA, Fuerst M, et al. Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection. J Virol. 2005; 79:4289–4297
Jones N, Agrawal D, Elrefaei M, et al. Evaluation of antigen-specific responses using in vitro enriched T cells. J Immunol Methods. 2003; 274:139–147